Probi and Vifor Pharma sign agreement to launch Probi Digestis® and Probi Defendum® in Switzerland

2012-05-08

Probi and Vifor Pharma sign agreement to launch Probi Digestis® and
Probi Defendum® in Switzerland

Probi has signed a distribution and co-marketing agreement with Vifor Pharma, a company of the Galenica Group, to launch Probi’s gut and immune health products on the Swiss pharmacy and drugstore market. The range will be sold under the Vitafor® umbrella brand and Probi Digestis® and Probi Defendum® product brands. The launch will take place in the fourth quarter of 2012 or the first quarter of 2013 and will be supported by strong consumer advertising and one of Switzerland’s best pharmacy sales forces.

Read the full release here